Citius Pharmaceuticals News, Citius Pharmaceuticals Quote, CTXR Quote

Citius Pharmaceuticals (NQ:CTXR) Delayed: 0.68 +0.04 (6.25%)

Prev. Close

$0.64

Today 6M 1Y 5Y

Open

$0.66

52 Wk High

$2.50

52 Wk Low

$0.40

Day High

$0.70

Day Low

$0.64

P/E

N/A

EPS

$0.00

Volume

442,362

Friends, Peers and Foes (?): CTOR MCK (more...)

ALERTS | RSS

Aug 5, 2026 04:19 PM Form 424B3 CITIUS ONCOLOGY, INC.
Aug 5, 2026 09:29 AM Form 8-K CITIUS ONCOLOGY, INC. For: Aug 05
Aug 5, 2026 09:27 AM Form 8-K Citius Pharmaceuticals, For: Aug 05
Aug 5, 2026 09:17 AM Citius Oncology Reports Strong Commercial Momentum for its Cancer Treatment
Jul 21, 2026 09:18 AM Citius Oncology expands LYMPHIR sales force ahead of August rollout
Jul 21, 2026 09:17 AM Citius Oncology Reports Nationwide Deployment of LYMPHIR's Broadened Commercial Organization and Expanding Market Adoption
Jun 8, 2026 06:03 AM Form EFFECT CITIUS ONCOLOGY, INC.
Jun 4, 2026 04:30 PM Form SCHEDULE 13D/A CITIUS ONCOLOGY, INC. Filed by: Citius Pharmaceuticals, Inc.
Jun 3, 2026 06:05 AM Form EFFECT Citius Pharmaceuticals,
Jun 1, 2026 04:46 PM Form 424B3 CITIUS ONCOLOGY, INC.

Entities mentioned with CTXR

View All Entities